Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States.
NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, United States.
Biochem Biophys Res Commun. 2023 Oct 20;678:122-127. doi: 10.1016/j.bbrc.2023.08.035. Epub 2023 Aug 21.
KRas4b is a membrane-bound regulatory protein belonging to the family of small GTPases that function as a molecular switch, facilitating signal transduction from activated membrane receptors to intracellular pathways controlling cell growth and proliferation. Oncogenic mutations locking KRas4b in the active GTP state are responsible for nearly 85% of all Ras-driven cancers. Understanding the membrane-bound state of KRas4b is crucial for designing new therapeutic approaches targeting oncogenic KRas-driven signaling pathways. Extensive research demonstrates the significant involvement of the membrane bilayer in Ras-effector interactions, with anionic lipids playing a critical role in determining protein conformations The preferred topology of KRas4b for interacting with signaling partners has been a long-time question. Computational studies suggest a membrane-proximal conformation, while other biophysical methods like neutron reflectivity propose a membrane-distal conformation. To address these gaps, we employed FRET measurements to investigate the conformation of KRas4b. Using fully post-translationally modified KRas4b, we designed a Nanodisc based FRET assay to study KRas4b-membrane interactions. We suggest an extended conformation of KRas4b relative to the membrane surface. Measurement of FRET donor - acceptor distances reveal that a negatively charged membrane surface weakly favors closer association with the membrane surface. Our findings provide insights into the role of anionic lipids in determining the dynamic conformations of KRas4b and shed light on the predominant conformation of its topology on lipid headgroups.
KRas4b 是一种膜结合的调节蛋白,属于小 GTP 酶家族,作为分子开关,促进从激活的膜受体到控制细胞生长和增殖的细胞内途径的信号转导。将 KRas4b 锁定在活性 GTP 状态的致癌突变负责近 85%的所有 Ras 驱动的癌症。了解 KRas4b 的膜结合状态对于设计针对致癌 KRas 驱动的信号通路的新治疗方法至关重要。广泛的研究表明,膜双层在 Ras-效应物相互作用中起着重要作用,阴离子脂质在确定蛋白质构象方面起着关键作用。KRas4b 与信号伙伴相互作用的首选拓扑结构一直是一个长期存在的问题。计算研究表明存在一种膜近端构象,而其他生物物理方法如中子反射率则提出了一种膜远端构象。为了解决这些差距,我们使用 FRET 测量来研究 KRas4b 的构象。使用完全翻译后修饰的 KRas4b,我们设计了基于 Nanodisc 的 FRET 测定法来研究 KRas4b-膜相互作用。我们提出了 KRas4b 相对于膜表面的扩展构象。FRET 供体-受体距离的测量表明,带负电荷的膜表面微弱地有利于与膜表面更紧密的结合。我们的发现提供了关于阴离子脂质在确定 KRas4b 动态构象中的作用的见解,并阐明了其在脂质头基上拓扑结构的主要构象。